JENNEREX BIOTHERAPEUTICS
Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company's lead product JX-594, currently in an international Phase 2 trial for primary liver cancer and colorectal cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse array of common cancers.
JENNEREX BIOTHERAPEUTICS
Industry:
Biopharma Biotechnology Medical
Founded:
2003-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.jennerex.com
Total Employee:
11+
Status:
Active
Contact:
14155982600
Email Addresses:
[email protected]
Total Funding:
56.05 M USD
Technology used in webpage:
Domain Not Resolving Apache GoDaddy DNS Sectigo SSL Sectigo Domain SSL GoDaddy Premium DNS Bizland
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Oncolix
Oncolix is a clinical-stage bio-pharmaceutical company developing a therapeutic protein for the treatment of cancer.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ottawa Regional Cancer Foundation
Ottawa Regional Cancer Foundation investment in Series C - Jennerex Biotherapeutics
Official Site Inspections
http://www.jennerex.com
- Host name: 172.67.195.218
- IP address: 172.67.195.218
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
